New drug inavolisib tested for Tough-to-Treat breast cancer
NCT ID NCT07347600
First seen Jan 21, 2026 · Last updated Jun 15, 2026 · Updated 15 times
Summary
This study is for people with a type of advanced breast cancer that has a specific gene change (PIK3CA) and has stopped responding to hormone therapy. It will track how well the drug inavolisib works and what side effects occur in about 500 participants in China. The goal is to see if this treatment can help control the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chongqing Cancer Hospital
RECRUITINGChongqing, 400030, China
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, 200032, China
-
Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Hospital of Traditional Chinese Medicine)
RECRUITINGLanzhou, Gansu, 730050, China
-
Guizhou Provincial People's Hospital
RECRUITINGGuiyang, 550002, China
-
Hainan Provincial Peoples Hospital
RECRUITINGHaikou, 570311, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, 150081, China
-
Hubei Cancer Hospital
RECRUITINGWuhan, 430079, China
-
Jiangsu Province Hospital
RECRUITINGNanjing, 210029, China
-
Jiangxi Cancer Hospital
RECRUITINGNanchang, 330006, China
-
Liaoning cancer Hospital & Institute
RECRUITINGShenyang, 110042, China
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
-
Peking University Third Hospital
RECRUITINGBeijing, 100191, China
-
Shandong Provincial Hospital
RECRUITINGJinan, 250021, China
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, 030013, China
-
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital
RECRUITINGChengdu, 610072, China
-
Subei People's Hospital of Jiangsu province
RECRUITINGYangzhou, 225001, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, 317000, China
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, 230022, China
-
The First Affiliated Hospital of Xian Jiao Tong University
RECRUITINGXi'an, China
-
The First Hospital of Jilin University
RECRUITINGChangchun, Jilin, 130021, China
-
Weifang People's Hospital
RECRUITINGWeifang, 261041, China
-
Wenzhou Medical University Affiliated Second Hospital
RECRUITINGWenzhou, Zhejiang, 325000, China
-
Zhujiang Hospital, Southern Medical University
RECRUITINGGuangzhou, 510280, China
Conditions
Explore the condition pages connected to this study.